In our present work, we used numerous clinical human melanoma samples, as well as, previously collected pathological datasets of disease progression to establish that the tumor-specific upregulation of myeloid checkpoint molecule, CD47, occurs at the mRNA level during melanomagenesis. This evidence concerns the gene CD47 and neoplasm.